Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Shares Outstanding: 2014-2021

  • HUTCHMED (China)'s Shares Outstanding rose 50.06% to $29,161.0 billion in Q4 2020 from the same period last year, while for Dec 2020 it was $29,161.0 billion, marking a year-over-year increase of 50.06%. This contributed to the annual value of $29,161.0 billion for FY2020, which is 50.06% up from last year.
  • HUTCHMED (China)'s Shares Outstanding amounted to $104.0 billion in Q2 2021, which was down 99.56% from $23,669.0 billion recorded in Q2 2020.
  • HUTCHMED (China)'s 5-year Shares Outstanding high stood at $29,161.0 billion for Q4 2020, and its period low was $1.0 billion during Q4 2016.
  • For the 2-year period, HUTCHMED (China)'s Shares Outstanding averaged around $24,296.8 billion, with its median value being $24,296.8 billion (2019).
  • Data for HUTCHMED (China)'s Shares Outstanding shows a maximum YoY plummeted of 99.56% (in 2021) over the last 5 years.
  • HUTCHMED (China)'s Shares Outstanding (Quarterly) stood at $1.0 billion in 2016, then reached $1.2 billion in 2017, then reached $19,432.6 billion in 2019, then spiked by 50.06% to $29,161.0 billion in 2020.
  • Its Shares Outstanding stands at $29,161.0 billion for Q4 2020, versus $19,432.6 billion for Q4 2019 and $1.2 billion for Q2 2017.